In 2017, the global prostate cancer diagnostics market attained a valuation of about US$ 10.0 Bn. It recorded a 7.7% average growth rate in the past few years. It will be encouraging for players to know that the market developed rapidly in the recent years.
However, in the next five years, the gross margin is expected to follow a declining trend. In 2017, it reached a 71.65%, reducing from a 73.15% touched in 2013.
Global Prostate Cancer Diagnostics Market: Drivers
One of the major factors augmenting the demand in the global prostate cancer diagnostics market is continuous technological development. On the other hand, increasing incidence of prostate cancer is raising the level of demand in the market.
Improving awareness about advanced cancer diagnostics technologies in developing economies and government initiatives taken to support it are expected to drive the growth of the global prostate cancer diagnostics market.
High demand for prostate cancer diagnostics in emerging countries such as China and Japan is strengthening the market. Furthermore, the availability of sophisticated healthcare infrastructure in North America is foreseen to promise growth to the prostate cancer diagnostics market.
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/149995/global-prostate-cancer-diagnostics-market
Global Prostate Cancer Diagnostics Market: Forecast by End User and Product
On the basis of end user, the global prostate cancer diagnostics market sees a classification into >75 years, 55-75 years, and <55 years. As per the findings of the report, end users aged between 55 and 75 years significantly increased the demand in the global prostate cancer diagnostics market. In 2017, this segmented accounted for a 69.0% share of the market.
By product, the global prostate cancer diagnostics market is segmented into biopsy, imaging, tumor biomarker tests, and others. In 2017, tumor biomarker tests bagged a 59.6% share of the market. However, the biopsy method is mostly used for prostate cancer diagnostics.
The global average gross margin of Prostate Cancer Diagnostics is in the decreasing trend, from 73.15% in 2013 to 71.65% in 2017. With the situation of global economy and technology, gross margin will be in decreasing trend in the following five years.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Tumor Biomarker Tests in 2017 is about 59.6%.
Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 69% in 2017.
The major players in global Prostate Cancer Diagnostics market include
- OPKO
- Genomic Health
- Abbott
- Beckman Coulter
- Siemens Healthcare
- bioMeriux
- Roche
- MDx Health
- DiaSorin
- Myriad Genetics
- Ambry Genetics
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Prostate Cancer Diagnostics in these regions, from 2013 to 2025 (forecast), covering
- North America
- Europe
- China
- Japan
- South America
- RoW
Global Prostate Cancer Diagnostics Market: Regional Analysis
By sales, North America takes the leading position in the global prostate cancer diagnostics market. In 2017, the region secured a consumption share of 47.7% in terms of value. In the same year, Europe treaded upon the heels of North America, collecting a 28.5% consumption share of the market.
North America is also the largest supplier that accounted for a 47.8% revenue share of the global prostate cancer diagnostics market in 2017. Europe achieved the second position in the same year as it secured a 39.0% revenue share of the market.
Global Prostate Cancer Diagnostics Market: Key Players
Siemens Healthcare, OPKO, Abbott, and Genomic Health are some of the players leading the global prostate cancer diagnostics market. These companies have secured strong positions in the market as they deal with premier customers and hold important patents and technologies.
Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer’s Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report
Get Amazing Discount on Market Research Report@ https://www.qyresearch.com/request-discount/form/149995/global-prostate-cancer-diagnostics-market
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Contact US
QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA – 91748
USA: +1 6262 952 442
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – enquiry@qyresearch.com
Web – www.qyresearch.com
Expert News: https://www.qyresearch.com/expert/list
